UF research opens new avenue for treatment of Alzheimer’s disease

More than 5 million Americans are currently coping with Alzheimer’s disease, but medications to halt the disease’s progression remain out of reach. New findings by neuroscientists at UF’s McKnight Brain Institute reveal the potential for a drug therapy to be developed that could one day stop progression of the debilitating neurodegenerative disorder.

Click here to read the news release.

Click here to read the paper, featured on the cover of the Journal of Experimental Medicine.

JEM cover
Cover of 2018 January Journal of Experimental Medicine
(from left) Todd Golde, M.D., Ph.D., Brenda D. Moore, Ph.D., and Diego Rincon-Limas
Drs. Golde, Rincon-Limas and Moore in their lab
Dr. Golde
Drs. Golde, Moore and Rincon-Limas